GT Biopharma (GTBP)
NASDAQ:GTBP
Holding GTBP?
Track your performance easily

GT Biopharma (GTBP) Technical Analysis

219 Followers

Technical Sentiment

Overall Consensus
Buy
13Bullish
5Neutral
4Bearish
Technical Analysis Consensus
Sell
2Bullish
5Neutral
3Bearish
Moving Average Consensus
Strong Buy
11Bullish
0Neutral
1Bearish
GT Biopharma’s (GTBP) Moving Averages Convergence Divergence (MACD) indicator is 0.24, suggesting GT Biopharma is a Sell.
GT Biopharma’s (GTBP) 20-Day exponential moving average is 2.83, while GT Biopharma’s (GTBP) share price is $3.33, making it a Buy.
GT Biopharma’s (GTBP) 50-Day exponential moving average is 2.58, while GT Biopharma’s (GTBP) share price is $3.33, making it a Buy.

GT Biopharma (GTBP) Pivot Points

Nov 10, 2024, 09:14 AM
Name
S3
S2
S1
Pivot Points
R1
R2
R3
Classic
2.65
2.76
2.93
3.04
3.21
3.32
3.49
Fibonacci
2.76
2.87
2.93
3.04
3.15
3.21
3.32
Pivot points are a technical analysis tool used by traders to identify potential support and resistance levels in financial markets. Pivot points are calculated based on the previous day's high, low, and close prices, and are used to help traders identify levels at which the price may reverse or continue to trend.

GT Biopharma (GTBP) Moving Averages

Nov 10, 2024, 09:14 AM
Period
Simple
Exponential
MA5
3.07Buy
3.13Buy
MA10
3.09Buy
3.03Buy
MA20
2.77Buy
2.83Buy
MA50
2.37Buy
2.58Buy
MA100
2.47Buy
2.74Buy
MA200
3.28Buy
3.65Sell
GT Biopharma’s (GTBP) 10-Day exponential moving average is 3.03, while GT Biopharma’s (GTBP) share price is $3.33, making it a Buy.
GT Biopharma’s (GTBP) 100-Day exponential moving average is 2.74, while GT Biopharma’s (GTBP) share price is $3.33, making it a Buy.
GT Biopharma’s (GTBP) stock price is $3.33 and GT Biopharma’s (GTBP) 50-day simple moving average is 2.37, creating a Buy signal.
GT Biopharma’s (GTBP) stock price is $3.33 and GT Biopharma’s (GTBP) 100-day simple moving average is 2.47, creating a Buy signal.
GT Biopharma’s (GTBP) stock price is $3.33 and GT Biopharma’s (GTBP) 200-day simple moving average is 3.28, creating a Buy signal.

GT Biopharma (GTBP) Technical Indicators

Nov 10, 2024, 09:14 AM
Name
Value
Implied Action
RSI (14)
70.15
Sell
STOCH (9,6)
49.62
Neutral
STOCHRSI (14)
69.76
Neutral
MACD (12,26)
0.24
Sell
ADX (14)
49.18
Neutral
Williams %R
-19.28
Sell
CCI (14)
87.45
Neutral
ATR (14)
0.25
-
Ultimate Oscillator
62.09
Neutral
ROC
37.60
Buy
GT Biopharma’s (GTBP) Relative Strength Index (RSI) is 70.15, creating a Sell signal.
GT Biopharma’s (GTBP) Trend Strength Indicator (ADX) is 49.18, creating a Neutral signal.
GT Biopharma’s (GTBP) Commodity Channel Index (CCI) is 87.45, creating a Neutral signal.
GT Biopharma’s (GTBP) Price Rate of Change (ROC) is 37.60, creating a Buy signal.

FAQ

Is GTBP a Buy, Hold, or Sell?
Based on GTBP’s technical indicators, GTBP is a Buy.
    What is GTBP’s RSI (14)?
    GTBP’s RSI (14) is 70.15, which suggests GTBP is a Sell.
      What is GTBP’s MACD?
      GTBP’s MACD is 0.24, which suggests GTBP is a Sell.
        What is GTBP’s 5-day moving average?
        GTBP’s 5-day moving average is 3.07, which suggests GTBP is a Buy.
          What is GTBP’s 20-day moving average?
          GTBP 20-day moving average is 2.77, which suggests GTBP is a Buy.
            What is GTBP’s 50-day moving average?
            GTBP’s 50-day moving average is 2.37, which suggests GTBP is a Buy.
              What is GTBP’s 200-day moving average?
              GTBP’s 200-day moving average is 3.28, which suggests GTBP is a Buy.
                What is GTBP’s Williams % R (14)?
                GTBP’s Williams % R (14) is -19.28, which suggests GTBP is a Sell.
                  What is GTBP’s CCI (14)?
                  GTBP’s CCI (14) is 87.45, which suggests GTBP is a Neutral.
                    What am I Missing?
                    Make informed decisions based on Top Analysts' activity
                    Know what industry insiders are buying
                    Get actionable alerts from top Wall Street Analysts
                    Find out before anyone else which stock is going to shoot up
                    Get powerful stock screeners & detailed portfolio analysis